期刊
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
卷 44, 期 2, 页码 125-130出版社
ELSEVIER TAIWAN
DOI: 10.1016/j.jmii.2010.06.001
关键词
Bacteremia; Carbapenem nonsusceptible; Escherichia coli
资金
- Chang Gung Memorial Hospital (CGMH), Taoyuan, Taiwan [CMRPG361233]
Background: Infections due to carbapenem-resistant Enterobacteriaceae have been the emerging problem worldwide. This primary object of this study was to understand the risk factors and clinical outcomes of carbapenem-nonsusceptible Escherichia coli (CNSEc) bacteremia. Methods: We conducted a matched case control study in a 3,715-bed tertiary care medical center in northern Taiwan. The controls were selected among patients with carbapenemsusceptible E coli and were matched with CNSEc for bacteremia. Results: Fifty-one patients were included in this study (17 cases and 34 controls). Bivariate analysis showed that prior exposure to carbapenems (p < 0.001), stay in intensive care units (p = 0.016), placement of central venous catheters (p = 0.001), chronic liver diseases (p < 0.001), uremia with regular dialysis (p = 0.004), and mechanical ventilation (p = 0.004) were associated with CNSEc bacteremia. Multivariate analysis revealed that prior exposure to carbapenems [odds ratio (OR), 29.17; 95% confidence interval (Cl), 1.76-484.70; p = 0.019], uremia with regular dialysis (OR, 98.58; 95% Cl, 4.02-999; p = 0.005) and chronic liver diseases (OR, 27.86; 95% Cl, 2.31-335.83; p = 0.009) were independent risk factors for CNSEc bacteremia. Compared with carbapenem-susceptible E coli group, CNSEc group had a longer hospital stay (68.4 days vs. 35.8 days; p = 0.04) and a higher disease severity, as indicated by a Pittsburgh bacteremia score greater than or equal to 4 (5.6% vs. 2.5%; p = 0.015). Patients with CNSEc bacteremia had a higher overall in-hospital mortality rate (94.12% vs. 50.00%; p = 0.002), but there was no difference in the 28-day mortality between these two groups. Conclusions: CNSEc bacteremia would lead to a poor outcome among patients with prior exposure to carbapenems, chronic liver disease, and uremia with regular dialysis. Copyright (C) 2011, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据